Literature DB >> 17845084

Beyond targets: consequences of vicarious exposure to misogyny at work.

Kathi Miner-Rubino1, Lilia M Cortina2.   

Abstract

The present study tested a model examining 2 indicators of a hostile interpersonal workplace climate for women-observed hostility (i.e., incivility and sexual harassment) toward women and perceived organizational unresponsiveness to sexual harassment--and how they relate to well-being and withdrawal for employees. Participants included 871 female and 831 male employees from a public university. According to structural equation analyses, observing hostility toward women and perceiving the organization as lax about harassment predict lower well-being, which translates into higher organizational withdrawal for both female and male employees. Results hold even after controlling for personal mistreatment, negative affectivity, and observed hostility toward men. These findings suggest that working in a misogynistic environment can have negative effects for all employees. (c) 2007 APA.

Entities:  

Mesh:

Year:  2007        PMID: 17845084     DOI: 10.1037/0021-9010.92.5.1254

Source DB:  PubMed          Journal:  J Appl Psychol        ISSN: 0021-9010


  3 in total

Review 1.  Discrimination, harassment, abuse, and bullying in the workplace: contribution of workplace injustice to occupational health disparities.

Authors:  Cassandra A Okechukwu; Kerry Souza; Kelly D Davis; A Butch de Castro
Journal:  Am J Ind Med       Date:  2013-06-27       Impact factor: 2.214

2.  Observed Workplace Incivility toward Women, Perceptions of Interpersonal Injustice, and Observer Occupational Well-Being: Differential Effects for Gender of the Observer.

Authors:  Kathi N Miner; Lilia M Cortina
Journal:  Front Psychol       Date:  2016-05-17

3.  Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal Mine.

Authors:  Linda J Hong; Lisa Rubinsak; Michelle F Benoit; Deanna Teoh; Uma Chandavarkar; Amy Brockmeyer; Erin Stevens; Yevgeniya Ioffe; Sarah M Temkin
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.